We’re delighted to receive $16.12 million through the State Government’s Victorian Higher Education State Investment Fund to enhance smart manufacturing, and #research and development commercialisation at Monash. 🧑🔬 Learn more: http://mona.sh/VA4w30rSINJ
#ChangeIt
We are hiring! University: Commercialisation Manager – Life Sciences. Great opportunity to join our team at Monash Innovation commercialising some of the amazing research @MonashUni @Monash_FMNHS @MIPS_Australia @MonashBDI https://www.linkedin.com/jobs/view/2649149480
More recently, clinician scientists @Kaufm020 (PMID: 32531207) and @lab_rezvani @may_daher (PMID: 32902645) have validated CISH as a checkpoint in human NK cells and CAR NK cells thus pushing this discovery closer to the clinic to benefit cancer patients
With our deep understanding of Natural Killer (NK) cells, we aim to be the first to master NK cell biology and therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.
We are driven by the challenge of engaging the immune system to fight cancer, and focused on delivering the first truly effective NK cell immunotherapies.
